Showing results (251-260 of 318) with videos related to

Sort By:
Pageof 32
Cancers|April 3, 2021
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Mario Giuliano, Fabiola Giudici, et al.
Phytotherapy Research : PTR|June 26, 2024
Anti-inflammatory and anti-hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis-associated visceral painMaria Loreta Libero, Elena Lucarini, Lucia Recinella, et al.
Cancer Treatment Reviews|December 22, 2024
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysisFrancesco Schettini, Sabrina Nucera, Tomás Pascual, et al.
Breast (Edinburgh, Scotland)|July 15, 2018
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) studyMatteo Lambertini, Valeria Fontana, Claudia Massarotti, et al.
Clinical Breast Cancer|November 19, 2019
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational StudyBenedetta Conte, Alessandra Fabi, Francesca Poggio, et al.
Tumori|October 10, 2014
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysisElena Collovà, Antonella Ferzi, Giuseppa Scandurra, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2020
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trialBenedetta Conte, Marco Bruzzone, Matteo Lambertini, et al.
Cells|April 12, 2024
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort StudyAndrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, et al.
Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumorsEleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
Pageof 32